STRATA Skin Sciences, Inc. (SSKN)

OTCMKTS · Delayed Price · Currency is USD
0.1850
+0.0140 (8.19%)
At close: Feb 20, 2026
Market Cap1.09M -90.8%
Revenue (ttm)30.98M -5.2%
Net Income-10.87M
EPS-2.56
Shares Out5.89M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume325,957
Average Volume1,227,475
Open0.1701
Previous Close0.1710
Day's Range0.1701 - 0.2483
52-Week Range0.1202 - 3.8600
Beta0.32
RSI18.50
Earnings DateMar 27, 2026

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy syste... [Read more]

Sector Healthcare
Founded 1989
Employees 106
Stock Exchange OTCMKTS
Ticker Symbol SSKN
Full Company Profile

Financial Performance

In 2024, STRATA Skin Sciences's revenue was $33.56 million, an increase of 0.61% compared to the previous year's $33.36 million. Losses were -$10.09 million, -6.87% less than in 2023.

Financial Statements

News

Strata Skin Sciences (SSKN) Delists Shares from Nasdaq

Strata Skin Sciences (SSKN) Delists Shares from Nasdaq

1 day ago - GuruFocus

STRATA Skin Sciences files to delist, plans to go dark

STRATA Skin Sciences (SSKN) files Form 25; Nasdaq trading suspended Feb 19, 2026. Form 15 next may end SEC reporting (“going dark”).

1 day ago - Seeking Alpha

STRATA Skin Sciences Confirms Nasdaq Delisting

HORSHAM, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and market...

1 day ago - GlobeNewsWire

STRATA Skin Sciences (SSKN) Enhances Dermatology Care at Johns Hopkins

STRATA Skin Sciences (SSKN) Enhances Dermatology Care at Johns Hopkins

2 days ago - GuruFocus

Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser

HORSHAM, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative dermatologic ...

2 days ago - GlobeNewsWire

Strata Skin Sciences (SSKN) Showcases Efficacy of 308 nm Excimer Laser for Psoriasis

Strata Skin Sciences (SSKN) Showcases Efficacy of 308 nm Excimer Laser for Psoriasis

3 days ago - GuruFocus

STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis

Growing body of clinical data like February 2026 publication from Georgetown University supports optimized, targeted Excimer laser UVB strategies for inflammatory skin conditions Growing body of clini...

3 days ago - GlobeNewsWire

Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences

LAGUNA HILLS, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Laseroptek America Corp. (“Laseroptek America” or “LOA”) today announced that it has filed counterclaims and third-party claims against Strata S...

9 days ago - GlobeNewsWire

STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico

HORSHAM, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies, announces its participation in the 2025 Ibero-Latin A...

2 months ago - GlobeNewsWire

STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. ( SSKN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Financial Officer ...

3 months ago - Seeking Alpha

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion

Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion Higher reimbursement, regulatory ...

3 months ago - GlobeNewsWire

STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update

HORSHAM, Penn., Nov. 05, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and mark...

3 months ago - GlobeNewsWire

Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company's XTR...

4 months ago - GlobeNewsWire

Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis

HORSHAM, Pa., Oct. 03, 2025 (GLOBE NEWSWIRE) -- In recognition of Eczema Awareness Month, STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated ...

5 months ago - GlobeNewsWire

STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis

HORSHAM, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marke...

5 months ago - GlobeNewsWire

New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach

Investigator-initiated randomized controlled combination trial published in the International Journal of Dermatology confirms its superiority to monotherapy, fueling continued market growth and expand...

5 months ago - GlobeNewsWire

STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering

HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marke...

6 months ago - GlobeNewsWire

STRATA Skin Sciences' Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements

Consulting program optimizes partner clinic businesses with implementation of best practices initiatives, including marketing, reimbursement, and patient retention Consulting program optimizes partner...

6 months ago - GlobeNewsWire

STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Fina...

6 months ago - Seeking Alpha

STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients

Peer-reviewed publications continue to validate Excimer Laser efficacy in vitiligo and treatment STRATA updates status of non-Excimer laser false advertising litigation HORSHAM, Pa., Aug. 07, 2025 (GL...

7 months ago - GlobeNewsWire

STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update

HORSHAM, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and market...

7 months ago - GlobeNewsWire

STRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Jules Abraham - CORE IR Dolev Rafaeli - Chief Executive Officer John Gillings - ...

10 months ago - Seeking Alpha

STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update

HORSHAM, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketi...

10 months ago - GlobeNewsWire

STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference

HORSHAM, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketi...

10 months ago - GlobeNewsWire

STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update

HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketi...

10 months ago - GlobeNewsWire